These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 25832906)

  • 1. Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.
    Hertz L; Chen Y; Waagepetersen HS
    J Neurochem; 2015 Jul; 134(1):7-20. PubMed ID: 25832906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of Abeta(1-42)-induced memory impairment in day-old chick by facilitation of astrocytic oxidative metabolism: implications for Alzheimer's disease.
    Gibbs ME; Gibbs Z; Hertz L
    J Neurochem; 2009 May; 109 Suppl 1():230-6. PubMed ID: 19393032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
    Heininger K
    Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability.
    Allaman I; Gavillet M; Bélanger M; Laroche T; Viertl D; Lashuel HA; Magistretti PJ
    J Neurosci; 2010 Mar; 30(9):3326-38. PubMed ID: 20203192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
    VanItallie TB
    Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases.
    Jensen NJ; Wodschow HZ; Nilsson M; Rungby J
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of neurotransmitter glutamate is diminished when beta-hydroxybutyrate replaces glucose in cultured neurons.
    Lund TM; Risa O; Sonnewald U; Schousboe A; Waagepetersen HS
    J Neurochem; 2009 Jul; 110(1):80-91. PubMed ID: 19457063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal-glial interactions in rats fed a ketogenic diet.
    Melø TM; Nehlig A; Sonnewald U
    Neurochem Int; 2006; 48(6-7):498-507. PubMed ID: 16542760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.
    Yao J; Chen S; Mao Z; Cadenas E; Brinton RD
    PLoS One; 2011; 6(7):e21788. PubMed ID: 21747957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.
    Reger MA; Henderson ST; Hale C; Cholerton B; Baker LD; Watson GS; Hyde K; Chapman D; Craft S
    Neurobiol Aging; 2004 Mar; 25(3):311-4. PubMed ID: 15123336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease.
    Zilberter M; Ivanov A; Ziyatdinova S; Mukhtarov M; Malkov A; Alpár A; Tortoriello G; Botting CH; Fülöp L; Osypov AA; Pitkänen A; Tanila H; Harkany T; Zilberter Y
    J Neurochem; 2013 Apr; 125(1):157-71. PubMed ID: 23241062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease.
    Cunnane SC; Courchesne-Loyer A; St-Pierre V; Vandenberghe C; Pierotti T; Fortier M; Croteau E; Castellano CA
    Ann N Y Acad Sci; 2016 Mar; 1367(1):12-20. PubMed ID: 26766547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid β 1-42 induces hypometabolism in human stem cell-derived neuron and astrocyte networks.
    Tarczyluk MA; Nagel DA; Rhein Parri H; Tse EH; Brown JE; Coleman MD; Hill EJ
    J Cereb Blood Flow Metab; 2015 Aug; 35(8):1348-57. PubMed ID: 25853906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketone body synthesis in the brain: possible neuroprotective effects.
    Guzmán M; Blázquez C
    Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):287-92. PubMed ID: 14769487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease.
    Broom GM; Shaw IC; Rucklidge JJ
    Nutrition; 2019 Apr; 60():118-121. PubMed ID: 30554068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity.
    Vincent AJ; Gasperini R; Foa L; Small DH
    J Alzheimers Dis; 2010; 22(3):699-714. PubMed ID: 20847426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture.
    Edmond J; Robbins RA; Bergstrom JD; Cole RA; de Vellis J
    J Neurosci Res; 1987; 18(4):551-61. PubMed ID: 3481403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet.
    Takeishi J; Tatewaki Y; Nakase T; Takano Y; Tomita N; Yamamoto S; Mutoh T; Taki Y
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.